Forum Financial Management LP Acquires 28,879 Shares of Sanofi (NASDAQ:SNY)

Forum Financial Management LP boosted its holdings in Sanofi (NASDAQ:SNY - Free Report) by 76.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 66,827 shares of the company's stock after acquiring an additional 28,879 shares during the quarter. Forum Financial Management LP's holdings in Sanofi were worth $3,223,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SNY. Arkadios Wealth Advisors raised its holdings in Sanofi by 19.0% in the 4th quarter. Arkadios Wealth Advisors now owns 4,709 shares of the company's stock worth $227,000 after acquiring an additional 751 shares during the period. Kentucky Trust Co bought a new stake in shares of Sanofi during the 4th quarter valued at $436,000. Van ECK Associates Corp raised its position in shares of Sanofi by 18.1% during the 4th quarter. Van ECK Associates Corp now owns 662,762 shares of the company's stock valued at $31,965,000 after acquiring an additional 101,726 shares during the last quarter. Sound Income Strategies LLC increased its position in shares of Sanofi by 156,520.9% during the fourth quarter. Sound Income Strategies LLC now owns 67,347 shares of the company's stock worth $3,248,000 after acquiring an additional 67,304 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its holdings in Sanofi by 128.0% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 115,330 shares of the company's stock worth $5,558,000 after purchasing an additional 64,747 shares during the last quarter. Hedge funds and other institutional investors own 14.04% of the company's stock.

Analyst Ratings Changes

A number of analysts have commented on the stock. Sanford C. Bernstein upgraded shares of Sanofi to a "strong-buy" rating in a research note on Thursday, January 30th. The Goldman Sachs Group began coverage on shares of Sanofi in a research report on Friday, March 21st. They set a "neutral" rating and a $65.00 target price on the stock. Deutsche Bank Aktiengesellschaft raised shares of Sanofi from a "sell" rating to a "hold" rating in a research note on Thursday, January 30th. Hsbc Global Res raised shares of Sanofi to a "strong-buy" rating in a research note on Monday, April 28th. Finally, BNP Paribas began coverage on shares of Sanofi in a research note on Tuesday, April 15th. They issued an "outperform" rating and a $65.00 price objective on the stock. Three analysts have rated the stock with a hold rating, two have assigned a buy rating and three have issued a strong buy rating to the company. According to MarketBeat.com, Sanofi currently has an average rating of "Buy" and an average price target of $63.33.

Sanofi Stock Up 0.1%

Shares of Sanofi stock traded up $0.08 during trading on Thursday, reaching $52.07. 1,448,452 shares of the company traded hands, compared to its average volume of 2,379,779. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.46 and a quick ratio of 1.14. Sanofi has a 1-year low of $45.80 and a 1-year high of $60.12. The company has a 50 day moving average price of $52.45 and a 200-day moving average price of $51.90. The firm has a market capitalization of $131.53 billion, a PE ratio of 20.92, a P/E/G ratio of 1.01 and a beta of 0.55.

Sanofi (NASDAQ:SNY - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The company reported $0.94 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.04. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. The firm had revenue of $10.41 billion for the quarter, compared to the consensus estimate of $9.79 billion. During the same quarter in the prior year, the company posted $1.78 earnings per share. The business's revenue was down 11.0% on a year-over-year basis. As a group, equities research analysts expect that Sanofi will post 4.36 earnings per share for the current fiscal year.

Sanofi Increases Dividend

The company also recently announced an annual dividend, which will be paid on Thursday, June 12th. Stockholders of record on Friday, May 9th will be paid a $2.0369 dividend. This is a positive change from Sanofi's previous annual dividend of $1.48. The ex-dividend date is Friday, May 9th. This represents a dividend yield of 3.1%. Sanofi's dividend payout ratio is presently 57.14%.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.